V-Square Quantitative Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-219
Closed -$27.9K 707
2025
Q1
$27.9K Buy
219
+10
+5% +$1.54K ﹤0.01% 650
2024
Q4
$30.1K Hold
209
﹤0.01% 634
2024
Q3
$31.1K Sell
209
-488
-70% -$70K ﹤0.01% 602
2024
Q2
$87.9K Buy
697
+133
+24% +$20.8K 0.01% 541
2024
Q1
$104K Hold
564
0.01% 536
2023
Q4
$101K Buy
564
+245
+77% +$38.1K 0.02% 534
2023
Q3
$50.7K Hold
319
0.02% 498
2023
Q2
$45.1K Buy
+319
New +$51.1K 0.03% 305

Other funds holding RGEN

V-Square Quantitative Management's RGEN Position: Q2 2025 in Review

V-Square Quantitative Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 219 shares — an estimated $27.9K sold.

V-Square Quantitative Management first reported a position in RGEN in Q2 2023 and held it in 8 quarters. The position peaked at $104K in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • V-Square Quantitative Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • V-Square Quantitative Management sold 219 Repligen shares in Q2 2025, an estimated $27.9K.
  • V-Square Quantitative Management first reported a position in Repligen in Q2 2023 and held it in 8 quarters.
  • V-Square Quantitative Management's Repligen position peaked at $104K in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on V-Square Quantitative Management's 13F filing for Q2 2025, filed 17 Jul 2025.